Skip to content

Dossier · PLMR · Dormant

PLMR · Palomar Holdings, Inc. · Stock research

Last analysed ·

Current thesis

Diversified specialty-insurance compounder: GWP +42% to $629.8M in Q1 (2026-05-06), FY26 adjusted-income guide lifted to $262–278M at 20%+ ROE. But the stock has stalled ~8% under its $147.62 high, sell-side is splitting, and the 2026-08-03 Q2 print is the next binary a compounder digesting, not an accelerating breakout.

Invalidation trigger

A weekly close below $120 breaks the post-Q1 consolidation floor and the base off the $100.81 low; secondary, Q2 (2026-08-03) GWP growth decelerating below ~30% or combined ratio pushing toward 90% breaks the profitable-growth frame.

Thesis status

Open commitment catalyst in 19dscored if the trigger above fires How this is scored →

Latest analysis and events for PLMR —

As of 2026-07-11, orbyd's latest analysis for Palomar Holdings, Inc. (PLMR): Diversified specialty-insurance compounder: GWP +42% to $629.8M in Q1 (2026-05-06), FY26 adjusted-income guide lifted to $262–278M at 20%+ ROE. But the stock has stalled ~8% under its $147.62 high, sell-side is splitting, and the 2026-08-03 Q2 print is the next binary a compounder digesting, not an accelerating breakout.

Invalidation trigger: A weekly close below $120 breaks the post-Q1 consolidation floor and the base off the $100.81 low; secondary, Q2 (2026-08-03) GWP growth decelerating below ~30% or combined ratio pushing toward 90% breaks the profitable-growth frame.

Next dated event on file: — catalyst in 19d.

Current Thesis

Palomar is a diversified specialty property-and-casualty compounder mid-transformation from a mono-line earthquake insurer into a multi-line E&S franchise. Q1 2026 (reported 2026-05-06) showed gross written premium up 42.4% to $629.8M and management lifting the FY26 adjusted-income guide to $262–278M at 20%+ adjusted ROE. The fundamental engine is intact, but the tape has stalled roughly 8% under the $147.62 high, the multiple has compressed to ~13x forward, and sell-side is splitting rather than piling in. This is a quality growth name in a MATURING, pre-earnings digestion a compounder consolidating, not an accelerating breakout. The 2026-08-03 Q2 print is the next binary.

Bullish and bearish views on Palomar Holdings, Inc.

The model's bull view on Palomar Holdings, Inc. (PLMR), in brief: GWP +42.4% YoY to $629.8M in Q1 2026 (from $442.2M), broad-based across Casualty, Inland Marine & Property, Crop, and Surety & Credit reported 2026-05-06. The bear view: GAAP net income was flat YoY at $42.9M ($1.57 diluted EPS) in Q1 2026 the entire growth story lives in the "adjusted" line, not reported earnings. Both cases follow in full.

Bull Case

  • GWP +42.4% YoY to $629.8M in Q1 2026 (from $442.2M), broad-based across Casualty, Inland Marine & Property, Crop, and Surety & Credit reported 2026-05-06.
  • Adjusted net income +23.1% to $63.1M ($2.31 adjusted diluted EPS) in Q1; FY26 adjusted-income guide raised to $262–278M, ~24% growth at the midpoint, with adjusted ROE above the 20% "Palomar 2X" bar (target hit early, in 2024).
  • Franchise de-risking off earthquake concentration: Casualty GWP grew 161% in 2024; Crop broadened via the Advanced AgProtection deal (Q2 2025) and the Gray acquisition closed 2026-01-31.
  • Capital-return signal: $200M buyback authorized 2026-05-06, running through 2028-05-06 a standing bid on weakness.
  • Cheap for the growth rate: ~19x trailing / ~13.3x forward P/E on ~24% earnings growth. KBW (Meyer Shields) raised its target to $166 on 2026-07-08, maintaining Outperform.

Bear Case

  • GAAP net income was flat YoY at $42.9M ($1.57 diluted EPS) in Q1 2026 the entire growth story lives in the "adjusted" line, not reported earnings.
  • Combined ratio deteriorated to 84.5% from 73.1% a year earlier; loss ratio jumped to 33.3%. Underwriting margin is compressing as the mix shifts toward higher-loss-ratio Casualty and Crop.
  • Sell-side is diverging, not accelerating: Evercore cut to $152 (2026-07-10), J.P. Morgan to $150 (2026-05-26), and Piper Sandler sits at $132 (2026-06-18) below the current price at the low end.
  • Cat-exposed book (earthquake, wind) carries tail risk into Atlantic hurricane season; a large event previously forced a reinsurance-line repricing.
  • Low-beta (0.41) name with no momentum bid; price has rolled over from the $147.62 high with no fresh catalyst until the print.

Setup & Price Structure

  • Last ~$136.07 (2026-07-10, -2.23% on the day, $133.44 after-hours), about 8% below the 52-week high of $147.62 and ~35% above the 52-week low of $100.81.
  • Consolidating below the highs into the Aug print; the tape is digestion, and an entry here is buying a stalled range ahead of a binary rather than chasing strength.
  • Valuation compressed to ~19x trailing / ~13.3x forward on a $3.61B market cap (~26.5M shares outstanding).
  • The $120 area is the floor of the post-Q1 range; a break there erases the multi-month base built off the $100.81 low.

Catalyst Calendar (next 30 days)

  • 2026-08-03 Q2 2026 earnings (confirmed). The binary: is GWP growth still 40%+, is the combined ratio stabilizing off the 84.5% Q1 mark, and does the FY26 guide move again.
  • Ongoing $200M buyback (through 2028-05-06) provides support on pullbacks.
  • Aug–Oct Atlantic hurricane season and reinsurance-pricing headlines can move the earthquake/wind-exposed lines independent of the equity tape.

What Would Change Our Mind

  • A weekly close below $120 breaks the post-Q1 consolidation floor and the base off the $100.81 low, flipping the structure from digestion to distribution.
  • Q2 (2026-08-03) GWP growth decelerating below ~30%, or the combined ratio pushing toward 90%, would break the "profitable-growth compounder" frame that justifies the premium-to-peers narrative.
  • A further cluster of price-target cuts or an outright downgrade would confirm the story has flipped from acceleration to plateau.

Correlation Notes

  • Trades with specialty P&C / E&S insurers (hard-market beneficiaries) and mid-cap financials; low beta (0.41) means it lags broad risk-on rallies and cushions in drawdowns.
  • Cat-exposed lines correlate to hurricane/earthquake event risk and reinsurance pricing cycles, not the equity index.
  • The inherited "managed-care / health-services" theme tag is a misclassification Palomar writes specialty property & casualty (earthquake, casualty, crop, inland marine, surety) and has no health-insurance exposure.

Notes

  • Q2 2026 earnings confirmed 2026-08-03 binary print, treat as blackout inside 3 trading days.
  • Theme tag corrected: NOT managed-care/health-services; Palomar is specialty P&C (earthquake, casualty, crop, inland marine, surety).
  • Watch combined ratio: 84.5% in Q1 2026 vs 73.1% a year earlier underwriting margin compressing as mix shifts to Casualty/Crop.
  • GAAP net income flat YoY ($42.9M) while adjusted grew +23% the growth narrative depends on the adjusted line.
  • Analyst PTs splitting: KBW $166 (raise, 07-08) vs Evercore $152 (cut, 07-10), JPM $150, Piper $132.
  • $200M buyback authorized 2026-05-06 through 2028-05-06 standing bid on weakness.

Related · shared themes

OSCR

Oscar Health, Inc.

Margin-recovery re-rate has carried the ACA pure-play leader to new highs, clearing the $30.38 prior 52-wk high on the +11% July 1 break with managed-care breadth (CNC/MOH/AGL) accelerating. But at $30.54 it trades ~28% above the $23.8 consensus target into the Aug 6 Q2 binary a late-leg continuation, not a pre-consensus entry.

MEDIUM

CNC

Centene Corporation

Managed-care margin recovery off the 2025 ACA blowup is largely priced (+137% off the $25.08 low into the low-$60s). The fresher driver is 2027 repricing ~14% ACA rate-hike filings (WSJ 2026-07-08) signal a hot medical-cost trend that pressures 2026 HBR before rates reset. The ~2026-07-28 Q2 print is the binary that settles recovery vs cost-catch-up. Theme MATURING→SATURATED.

LOW

HUM

Humana Inc.

Medicare Advantage margin-recovery re-rate; the 2027 CMS +2.48% rate print doubled HUM off $163, but the discovery catalyst is spent and price ~$382 sits above the $304 average target. The ~2026-07-30 Q2 print is now the binary inside the window a chase at all-time highs, not a fresh setup.

LOW

PURR

Hyperliquid Strategies Inc

Hyperliquid proxy has decoupled from a broken crypto tape (BTC sub-$60k, -50% from ATH) and is squeezing on idiosyncratic flow: Russell 2000/3000 reconstitution (effective ~6/29), a small-float gamma-squeeze setup, and HYPE-token relative strength. The bid is mechanical and speculative, not narrative-clean index demand is largely a 6/26-close event with sell-the-news risk, and the 35.16M-share secondary still overhangs.

LOW

See also · stocks to watch